Antibody

1,032개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,032 programs
AntibodyLimited DatastaleTianjin Medical University Canc…Phase 2

trastuzumab (Herceptin, Pyrrolidine、trastuzumab、AI)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#monoclonal-antibody#Tianjin
Trials 1Status Active
AntibodyLimited DatastaleThe First Affiliated Hospital w…Phase 2

Iparomlimab/Tuvonralimab (QL1706, QL1706 (Iparomlimab/Tuvonralimab))

Gastric Cancer Stage III · Gastric Cancer Stage III

#GastricCancerStageIII#Antibody#Phase2#monoclonal-antibody#The
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenPhase 2

daratumumab (Darzalex, QL2109 or Daratumumab)

Relapsed or Refractory Multiple Myeloma · FRα

#FR#Antibody#Phase2#monoclonal-antibody#RelapsedorRefractoryMultipleMyel+1
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

QLS5132; Bevacizumab (QLS5132; Bevacizumab)

Gastric Cancer (GC); Non-small Cell Lung Cancer (NSCLC) · Gastric Cancer (GC)

#GastricCancerGC#Antibody#Phase2#monoclonal-antibody#Non-smallCellLungCancerNSCLC+1
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

QLS5132; Platinum; Bevacizumab (QLS5132; Platinum; Bevacizumab)

Gastric Cancer (GC); Non-small Cell Lung Cancer (NSCLC) · Gastric Cancer (GC)

#GastricCancerGC#Antibody#Phase2#monoclonal-antibody#Non-smallCellLungCancerNSCLC+1
Trials 1Status Recruiting
AntibodyLimited DatastaleGerman High-Grade Non-Hodgkin's…Phase 3

R-CHOEP 14 with 12x Rituximab (R-CHOEP 14 with 12x Rituximab)

Non-Hodgkin's Lymphoma (NHL) · Non-Hodgkin's Lymphoma (NHL)

#Non-HodgkinsLymphomaNHL#Antibody#Phase3#monoclonal-antibody#German
Trials 1Status Active
AntibodyLimited DatastaleEli LillyPhase 1

RAD001, Cetuximab, Irinotecan (RAD001, Cetuximab, Irinotecan)

Colorectal Cancer; Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#monoclonal-antibody#ColorectalCarcinoma+1
Trials 1Status Active
AntibodyLimited DatastaleRegeneronPhase 2

REGN15505+Cemiplimab (REGN15505+Cemiplimab)

Metastatic Castration-Resistant Prostate Cancer (mCRPC); Clear Cell Renal Cell Carcinoma (ccRCC) · Metastatic Castration-Resistant Prostate

#MetastaticCastration-ResistantPr#Antibody#Phase2#monoclonal-antibody#ClearCellRenalCellCarcinomaccRCC+1
Trials 1Status Recruiting
AntibodyLimited DatastaleRegeneron PharmaceuticalsPhase 2

REGN17372+Linvoseltamab (REGN17372+Linvoseltamab)

Relapsed Refractory Multiple Myeloma (RRMM) · FRα

#FR#Antibody#Phase2#monoclonal-antibody#RelapsedRefractoryMultipleMyelom+1
Trials 1Status Recruiting
AntibodyLimited DatastaleSanofiPhase 2

REGN3500 + Dupilumab Combo (REGN3500 + Dupilumab Combo)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Phase2#monoclonal-antibody#Sanofi
Trials 1Status Discontinued
AntibodyLimited DatastaleHoffmann-La RochePhase 1

RO5323441 + bevacizumab [Avastin] (RO5323441 + bevacizumab [Avastin])

Glioblastoma Multiforme · Glioblastoma Multiforme

#GlioblastomaMultiforme#Antibody#Phase1#monoclonal-antibody#Hoffmann-La
Trials 1Status Active
AntibodyLimited DatastaleHoffmann-La RochePhase 1

atezolizumab (Tecentriq, RO7567132 and Atezolizumab)

Cancer-Neoplasms · Cancer-Neoplasms

#Cancer-Neoplasms#Antibody#Phase1#monoclonal-antibody#Hoffmann-La
Trials 1Status Recruiting
AntibodyLimited DatastaleAssociazione Volontari Pazienti…Phase 3

RT+CETUXIMAB (RT+CETUXIMAB)

Head and Neck Squamous Cell Carcinoma · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase3#monoclonal-antibody#Associazione
Trials 1Status Active
AntibodyLimited DatastaleEli Lilly and CompanyPhase 1

IMC-1121B (Ramucirumab, Ramucirumab (IMC-1121B))

Colorectal Carcinoma · Colorectal Carcinoma

#ColorectalCarcinoma#Antibody#Phase1#monoclonal-antibody#Eli
Trials 1Status Active
AntibodyLimited DatastaleEli Lilly and CompanyPhase 2

Ramucirumab DP (Ramucirumab DP)

Carcinoma of Urinary Tract; Urethral Carcinoma · Carcinoma of Urinary Tract

#CarcinomaofUrinaryTract#Antibody#Phase2#monoclonal-antibody#UrethralCarcinoma+1
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

Recombinant Human Interleukin-2 and Rituximab (Recombinant Human Interleukin-2 and Rituximab)

Lymphoma, Non-Hodgkin · Lymphoma, Non-Hodgkin

#LymphomaNon-Hodgkin#Antibody#Phase2#monoclonal-antibody#Lymphoma+2
Trials 1Status Active
AntibodyLimited DatastaleZhejiang Cancer HospitalPhase 2

Recombinant human adenovirus type 5＋Camrelizumab (Recombinant human adenovirus type 5＋Camrelizumab)

Uterine Cervical Neoplasms; Oncolytic Virotherapy · Uterine Cervical Neoplasms

#UterineCervicalNeoplasms#Antibody#Phase2#monoclonal-antibody#OncolyticVirotherapy+1
Trials 1Status Active
AntibodyLimited DatastaleTianjin Medical University Canc…Phase 2

Regorafenib and tislelizumab (Regorafenib and tislelizumab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#Tianjin
Trials 1Status Recruiting
AntibodyLimited DatastaleAsan Medical CenterPhase 2

nivolumab (Opdivo, Regorafenib/Nivolumab)

Carcinoma, Hepatocellular; Hepatoma · Carcinoma, Hepatocellular

#CarcinomaHepatocellular#Antibody#Phase2#monoclonal-antibody#Carcinoma+3
Trials 1Status Active
AntibodyLimited DatastaleWashington University School of…Phase 1

Relatilmab (Relatilmab)

Advanced Melanoma; Metastatic Melanoma · Advanced Melanoma

#AdvancedMelanoma#Antibody#Phase1#monoclonal-antibody#MetastaticMelanoma+1
Trials 1Status Recruiting

39 / 52 pages

← PreviousNext →